Dividend investing can boost returns, but picking resilient companies is key. Despite challenges in retail pharmacy, CVS Health stands out with a diversified business and a 3.4% dividend yield, well above the S&P 500 average. Moves to cut costs and refocus should help margins, and the dividend has remained steady. Johnson & Johnson’s 62-year streak of dividend hikes continues, even amid lawsuits and patent expirations. Its strong pipeline, steady revenue growth, and high credit rating suggest it can handle ongoing headwinds. Both CVS and JNJ remain solid picks for long-term dividend-focused investors.